Atlas Trials

A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects

Clinical trial NCT02111252 · COMPLETED

Trial details

NCT number
NCT02111252
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Influenza
Start date
2014-03-01
Primary completion
2014-04-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.